Stephen Basil Thomas - Insider Trading & Ownership

Entity
Individual
Location
2525 Smith Street, Scotch Plains, NJ
Summary
The estimated net worth of Stephen Basil Thomas is at least $1.47M dollars as of June 27, 2024. Stephen Basil Thomas is the Director of Eliem Therapeutics, Inc. and owns shares of Climb Bio, Inc. (CLYM) stock worth about $1.47M.
All Insider Reports
All Insider Reports

Ownership of Stephen Basil Thomas

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CLYM Climb Bio, Inc. Director $1.47M Jun 27, 2024

Insider Transactions Reported by Stephen Basil Thomas:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.